1998
DOI: 10.1002/1529-0131(199809)41:9<1521::aid-art2>3.0.co;2-a
|View full text |Cite
|
Sign up to set email alerts
|

Antineutrophil cytoplasmic antibodies

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

1
148
0
7

Year Published

1999
1999
2012
2012

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 375 publications
(161 citation statements)
references
References 188 publications
1
148
0
7
Order By: Relevance
“…Eleven candidate biomarkers, selected for ANCAs were not evaluated in the INSSYS study, but these autoantibodies also function poorly as biomarkers. Between 10% and 40% of all WG patients with active disease lack these antibodies altogether (25). Moreover, although persistent ANCA positivity appears to predict an increased likelihood of a disease flare at some point in the future, it does not predict the timing of such a flare and is not a reliable guide to therapy (25,26).…”
Section: Discussionmentioning
confidence: 99%
“…Eleven candidate biomarkers, selected for ANCAs were not evaluated in the INSSYS study, but these autoantibodies also function poorly as biomarkers. Between 10% and 40% of all WG patients with active disease lack these antibodies altogether (25). Moreover, although persistent ANCA positivity appears to predict an increased likelihood of a disease flare at some point in the future, it does not predict the timing of such a flare and is not a reliable guide to therapy (25,26).…”
Section: Discussionmentioning
confidence: 99%
“…However, 20 % of patients with GPA or MPA have the alternative ANCA, and at least 10 % of patients are ANCA negative [3][4][5]. In many cases, the ANCA titer will decrease or be 0 with remission induction therapy [4,6,7]. The main pathologic difference between GPA and MPA is the absence of granulomatous inflammation in MPA.…”
Section: Discussionmentioning
confidence: 99%
“…By IIF, P-ANCA may be identified in patients with systemic lupus erythematosus and may be difficult to distinguish from ANA (2,3,15,35,36,83). P-ANCA can be seen in various connective tissue diseases, such as in rheumatoid arthritis, inflammatory arthritis, progressive systemic sclerosis, and other disorders (4,33,38,84). In rheumatoid arthritis, granulocyte-specific ANA can closely resemble P-ANCA in IIF tests (3,5,38,82).…”
Section: Discussionmentioning
confidence: 99%
“…The pulmonary diseases that are most frequently associated with ANCA include Wegener's granulomatosis (WG), microscopic polyangiitis (MPA), Churg Strauss syndrome, and other disorders (2)(3)(4)(5). Elevated ANCA titers particularly occur during disease exacerbation but may be low or absent in remission (3,6,7).…”
mentioning
confidence: 99%
See 1 more Smart Citation